A

Anthropic

Builds Claude AI models with a focus on safety

CMC & Manufacturing Lead - Life Sciences

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeRemote in USA$300k - $320k /yr

About the Job

Requirements

  • Biotechnology or pharmaceutical industry experience leading CMC for gene therapy, gene editing, or nucleic acid products, including taking a product from preclinical development into the clinic.
  • Deep expertise in several of lipid nanoparticles (LNP), mRNA, guide RNA (gRNA), adeno-associated virus (AAV), and antisense oligonucleotides (ASO), and working knowledge of the others, including how they are manufactured, characterized, and released.
  • Deep understanding of GMP manufacturing and regulatory CMC requirements for genetic medicines, including writing or reviewing CMC sections of INDs or equivalent filings.
  • A strong track record of selecting and managing CDMOs, CROs, and other external partners, including technology transfer and quality oversight.
  • Demonstrated creativity in manufacturing novel products, shown by process, analytical, or supply solutions developed where no established precedent existed.
  • Ability to evaluate novel technologies rigorously from data and turn that evaluation into a clear recommendation.
  • Clear written and verbal communication, including explaining CMC tradeoffs to people outside the field.
  • Curiosity about how AI can change drug development and interest in Anthropic’s mission to build safe and beneficial AI.
  • Minimum education is a bachelor’s degree or an equivalent combination of education, training, and/or experience.
  • Required field of study is a field relevant to the role, as demonstrated through coursework, training, or professional experience.
  • Years of experience required will correlate with the internal job level requirements for the position.

Responsibilities

  • Guide CMC and manufacturing strategy for genetic medicines, from early development through clinical supply.
  • Serve as a CMC expert to external partners, reviewing process, analytical, and supply plans and resolving technical issues together.
  • Provide technical oversight of externally conducted process development, formulation, analytical development, fill-finish, stability, and release testing, with phase-appropriate specifications and control strategies.
  • Collaborate with scientists across disciplines to turn early research into robust, GMP-ready processes.
  • Oversee quality for externally manufactured material, including audits, quality agreements, and batch disposition.
  • Evaluate novel manufacturing, analytical, and delivery technologies, and make clear recommendations.
  • Develop approaches that reduce the time and cost of reaching clinical material without compromising product quality or patient safety.
  • Work with Anthropic researchers and engineers to identify where Claude can speed up CMC work, contribute to evaluations and tools, and test results against real-world problems.
  • Identify CMC and supply chain risks early, and communicate status, tradeoffs, and decisions clearly.

Desired Qualifications

  • 10+ years in the biotechnology or pharmaceutical industry, with a focus on CMC and gene therapy product development.
  • An advanced degree in chemical engineering, biochemistry, pharmaceutical sciences, molecular biology, or a related field.
  • Experience with rare disease or small-population programs, or with platform-based manufacturing and regulatory approaches.
  • Direct experience leading CMC discussions with the FDA and other health authorities, such as the EMA and MHRA.
  • Hands-on experience with GMP quality activities, such as vendor audits, quality agreements, deviation review, and batch disposition.
  • Experience building a CMC function or working in a fully outsourced model.
  • Experience with small-batch or rapid-turnaround GMP manufacturing and accelerated release testing.
  • Experience with technical due diligence on external technologies or manufacturing partners.
  • Hands-on experience using LLM tools like Claude in day-to-day work.

About the Company

Anthropic

Builds Claude AI models with a focus on safety

Anthropic builds the Claude family of AI models and sells them to businesses, software developers, and consumers, with research on making AI safe and understandable at the center of its work. In 2024 it introduced the Model Context Protocol, an open standard for connecting AI assistants to outside apps and data that OpenAI and Google adopted the next year. People use the Claude app to write and analyze files, programmers hand coding tasks to Claude Code, and companies build Claude into their own products through its API. Anthropic earns money from subscriptions, business plans, and usage-based API fees. Siblings Dario and Daniela Amodei founded Anthropic in 2021 with other former OpenAI employees, and it is based in San Francisco.

Company size
5,001-10,000
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Anthropic

See more jobs